ag-1296 has been researched along with Sarcoma, Ewing in 1 studies
6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase
Sarcoma, Ewing: A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uren, A | 1 |
| Merchant, MS | 1 |
| Sun, CJ | 1 |
| Vitolo, MI | 1 |
| Sun, Y | 1 |
| Tsokos, M | 1 |
| Illei, PB | 1 |
| Ladanyi, M | 1 |
| Passaniti, A | 1 |
| Mackall, C | 1 |
| Toretsky, JA | 1 |
1 other study available for ag-1296 and Sarcoma, Ewing
| Article | Year |
|---|---|
Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
Topics: Animals; Becaplermin; Bone Neoplasms; Cell Division; Chemotaxis; Class Ib Phosphatidylinositol 3-Kin | 2003 |